We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Medicare Payment Structures Contributing to Higher Drug Prices, Says Verma
Medicare Payment Structures Contributing to Higher Drug Prices, Says Verma
Manufacturers and providers have “perverse incentives” to set higher drug prices and pick pricier therapies for patients due to Medicare’s current payment structure, and the system isn’t suitable for expensive modern therapies, said Centers for Medicare and Medicaid Services Administrator Seema Verma at the American Hospital Association’s annual meeting in Washington, D.C.